Welcome our new technician

Parker Mathews joined the lab on 4/1/19 to serve as our new lab manager.

Posted in Uncategorized | Leave a comment

Daniel Feinberg enrolls in MD, PhD Program in Case Western University

Daniel Feinberg was accepted to the MD, PhD program at Case Western University/Cleveland Clinic and will be moving to Cleveland to pursue his education. Congrats Daniel!

Posted in Uncategorized | Leave a comment

Barry Paul’s new position in Levine Cancer Center

Barry Paul accepted a hematologist/oncologist position at the Levine Cancer Center in Charlotte, NC. Congratulations!

Posted in Uncategorized | Leave a comment

New paper published in Cancer Letter

Congratulations to Dr. Jing Zheng and Dr. Yonggang Sha for their co-first author paper published in Cancer Letter entitled “Pan-PIM kinase inhibitors enhance Lenalidomide’s anti-myeloma activity via cereblon-IKZF1/3 cascade”.

Posted in Uncategorized | Leave a comment

New paper from Journal of Hematology and Oncology

Kudos to Dr. Zhihong Zheng for her paper entitled “Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma” was published by Journal of Hematology and Oncology!

Posted in Uncategorized | Leave a comment

Paper accepted by Stem Cell Research & Therapy

Congrats to Pasupathi Sundaramoorthy for the acceptance of his paper in Stem Cell Research & Therapy on “Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice” in which he discovers a key role of thioredoxin in the regulation of radiation-induced hematopoietic stem cell injury. Great job!

Posted in Uncategorized | Leave a comment

Welcome to Kang Lab

Dr. Yubin Kang is an associate professor and hematologist/oncologist in the Division of Hematological Malignancies and Cellular Therapy at Duke University Medical Center. Kang lab focuses on blood and bone marrow cancers, especially on multiple myeloma. Besides, using state-of-the-art multiphoton and confocal optical imaging techniques, we are also interested in  the development of new approaches to enhance hematopoietic stem cell engraftment and reconstitution following blood and bone marrow transplant.

Posted in News | 1 Comment